Your browser doesn't support javascript.
loading
: 20 | 50 | 100
1 - 18 de 18
1.
bioRxiv ; 2024 May 14.
Article En | MEDLINE | ID: mdl-38798619

UM171 is a potent small molecule agonist of ex vivo human hematopoietic stem cell (HSC) self-renewal, a process that is tightly controlled by epigenetic regulation. By co-opting KBTBD4, a substrate receptor of the CULLIN3-RING E3 ubiquitin ligase complex, UM171 promotes the degradation of members of the CoREST transcriptional corepressor complex, thereby limiting HSC attrition. However, the direct target and mechanism of action of UM171 remain unclear. Here, we reveal that UM171 acts as a molecular glue to induce high-affinity interactions between KBTBD4 and HDAC1 to promote the degradation of select HDAC1/2 corepressor complexes. Through proteomics and chemical inhibitor studies, we discover that the principal target of UM171 is HDAC1/2. Cryo-electron microscopy (cryo-EM) analysis of dimeric KBTBD4 bound to UM171 and the LSD1-HDAC1-CoREST complex unveils an unexpected asymmetric assembly, in which a single UM171 molecule enables a pair of KBTBD4 KELCH-repeat propeller domains to recruit HDAC1 by clamping on its catalytic domain. One of the KBTBD4 propellers partially masks the rim of the HDAC1 active site pocket, which is exploited by UM171 to extend the E3-neo-substrate interface. The other propeller cooperatively strengthens HDAC1 binding via a separate and distinct interface. The overall neomorphic interaction is further buttressed by an endogenous cofactor of HDAC1-CoREST, inositol hexakisphosphate, which makes direct contacts with KBTBD4 and acts as a second molecular glue. The functional relevance of the quaternary complex interaction surfaces defined by cryo-EM is demonstrated by in situ base editor scanning of KBTBD4 and HDAC1. By delineating the direct target of UM171 and its mechanism of action, our results reveal how the cooperativity offered by a large dimeric CRL E3 family can be leveraged by a small molecule degrader and establish for the first time a dual molecular glue paradigm.

2.
J Am Chem Soc ; 145(12): 6811-6822, 2023 03 29.
Article En | MEDLINE | ID: mdl-36930461

The reversible acetylation of histone lysine residues is controlled by the action of acetyltransferases and deacetylases (HDACs), which regulate chromatin structure and gene expression. The sirtuins are a family of NAD-dependent HDAC enzymes, and one member, sirtuin 6 (Sirt6), influences DNA repair, transcription, and aging. Here, we demonstrate that Sirt6 is efficient at deacetylating several histone H3 acetylation sites, including its canonical site Lys9, in the context of nucleosomes but not free acetylated histone H3 protein substrates. By installing a chemical warhead at the Lys9 position of histone H3, we trap a catalytically poised Sirt6 in complex with a nucleosome and employ this in cryo-EM structural analysis. The structure of Sirt6 bound to a nucleosome reveals extensive interactions between distinct segments of Sirt6 and the H2A/H2B acidic patch and nucleosomal DNA, which accounts for the rapid deacetylation of nucleosomal H3 sites and the disfavoring of histone H2B acetylation sites. These findings provide a new framework for understanding how HDACs target and regulate chromatin.


Nucleosomes , Sirtuins , Histones/chemistry , Chromatin , Sirtuins/metabolism , Acetylation , Glycosyltransferases/metabolism , Catalysis
3.
Curr Opin Chem Biol ; 70: 102179, 2022 10.
Article En | MEDLINE | ID: mdl-35803024

Classical histone deacetylases (HDACs) are enzymes that can hydrolytically cleave acetyl-Lys in histones and other proteins and serve as established drug targets in some forms of cancer. Class I HDACs 1-3 typically exist in a range of multiprotein complexes inside cells and show distinct biological functions in modulating gene expression. In recent years, it has become possible to purify and analyze the structure and enzymatic properties of several of these HDAC complexes, including CoREST, MiDAC, NuRD, Sin3, SMRT, MIER, and RERE. Here, we summarize what is experimentally established and/or computationally predicted about the structure of these complexes to describe their particular catalytic activities and site-specificities with modified nucleosome substrates.


Histone Deacetylases , Histones , Histone Deacetylase Inhibitors , Histone Deacetylases/metabolism , Histones/chemistry , Multiprotein Complexes , Nucleosomes
4.
J Am Chem Soc ; 144(8): 3360-3364, 2022 03 02.
Article En | MEDLINE | ID: mdl-35175758

We describe a new method to produce histone H2B by semisynthesis with an engineered sortase transpeptidase. N-Terminal tail site-specifically modified acetylated, lactylated, and ß-hydroxybutyrylated histone H2Bs were incorporated into nucleosomes and investigated as substrates of histone deacetylase (HDAC) complexes and sirtuins. A wide range of rates and site-specificities were observed by these enzyme forms suggesting distinct biological roles in regulating chromatin structure and epigenetics.


Histones , Sirtuins , Chromatin , Histone Deacetylases/genetics , Histones/chemistry , Nucleosomes
5.
Angew Chem Int Ed Engl ; 60(51): 26489-26494, 2021 12 13.
Article En | MEDLINE | ID: mdl-34634172

DNA-protein cross-links (DPCs) between DNA epigenetic mark 5-formylC and lysine residues of histone proteins spontaneously form in human cells. Such conjugates are likely to influence chromatin structure and mediate DNA replication, transcription, and repair, but are challenging to study due to their reversible nature. Here we report the construction of site specific, hydrolytically stable DPCs between 5fdC in DNA and K4 of histone H3 and an investigation of their effects on DNA replication. Our approach employs oxime ligation, allowing for site-specific conjugation of histones to DNA under physiological conditions. Primer extension experiments revealed that histone H3-DNA crosslinks blocked DNA synthesis by hPol η polymerase, but were bypassed following proteolytic processing.


Cytosine/metabolism , DNA-Directed DNA Polymerase/metabolism , DNA/metabolism , Histones/metabolism , Cytosine/chemistry , DNA/chemistry , Histones/chemistry , Humans , Molecular Structure
6.
Mol Cancer Res ; 19(11): 1818-1830, 2021 11.
Article En | MEDLINE | ID: mdl-34285087

NUT carcinoma (NC), characterized most commonly by the BRD4-NUTM1 fusion, is a rare, aggressive variant of squamous carcinoma with no effective treatment. BRD4-NUT drives growth and maintains the poorly differentiated state of NC by activating pro-growth genes such as MYC, through the formation of massive, hyperacetylated, superenhancer-like domains termed megadomains. BRD4-NUT-mediated hyperacetylation of chromatin is facilitated by the chromatin-targeting tandem bromodomains of BRD4, combined with NUT, which recruits the histone acetyltransferase, p300. Here, we developed a high-throughput small-molecule screen to identify inhibitors of transcriptional activation by NUT. In this dCAS9-based GFP-reporter assay, the strongest hits were diverse histone deacetylase (HDAC) inhibitors. Two structurally unrelated HDAC inhibitors, panobinostat and the novel compound, IRBM6, both repressed growth and induced differentiation of NC cells in proportion to their inhibition of NUT transcriptional activity. These two compounds repressed transcription of megadomain-associated oncogenic genes, such as MYC and SOX2, while upregulating pro-differentiation, non-megadomain-associated genes, including JUN, FOS, and key cell-cycle regulators, such as CDKN1A. The transcriptional changes correlate with depletion of BRD4-NUT from megadomains, and redistribution of the p300/CBP-associated chromatin acetylation mark, H3K27ac, away from megadomains toward regular enhancer regions previously populated by H3K27ac. In NC xenograft models, we demonstrated that suppression of tumor growth by panobinostat was comparable with that of bromodomain inhibition, and when combined they improved both survival and growth suppression. IMPLICATIONS: The findings provide mechanistic and preclinical rationale for the use of HDAC inhibitors, alone or combined with other agents, in the treatment of NUT carcinoma.


Carcinoma, Squamous Cell/drug therapy , Carcinoma, Squamous Cell/genetics , Cell Cycle Proteins/genetics , Early Detection of Cancer/methods , High-Throughput Nucleotide Sequencing/methods , Histone Deacetylase Inhibitors/therapeutic use , Nuclear Proteins/genetics , Transcription Factors/genetics , Animals , Cell Line, Tumor , Female , Histone Deacetylase Inhibitors/pharmacology , Humans , Male , Mice
7.
Biotechnol Appl Biochem ; 67(6): 824-834, 2020 Nov.
Article En | MEDLINE | ID: mdl-33146902

Genome engineering and synthetic biology as an emerging interdisciplinary tool have opened a new era for energy research as well as life science. In this study, bibliometric and content analysis were conducted to clarify research characteristics and research trends in this field. Our result revealed that USA, China, UK, Germany, and France were the main contributing countries, and USA was in a leading position in international cooperation. The CRISPR-Cas9 system has been manipulated to develop microorganisms with improved characteristics and tolerance, and is at the forefront of research and practice. In addition, design and construction of synthetic microbial communities and optimization of ecological models to meet industrial demands will become the next hotspot. Meanwhile, effective process configurations that can promote commercial-scale biofuel production should also be developed. Genome engineering and synthetic biology are expected to continue playing an important role in promoting the development of sustainable energy production.


Bibliometrics , Biofuels , Metabolic Engineering , Microbiota , Models, Biological , Synthetic Biology
8.
Cell Chem Biol ; 27(8): 953-969, 2020 08 20.
Article En | MEDLINE | ID: mdl-32698016

Lysine (Lys) residues in proteins undergo a wide range of reversible post-translational modifications (PTMs), which can regulate enzyme activities, chromatin structure, protein-protein interactions, protein stability, and cellular localization. Here we discuss the "writers," "erasers," and "readers" of some of the common protein Lys PTMs and summarize examples of their major biological impacts. We also review chemical biology approaches, from small-molecule probes to protein chemistry technologies, that have helped to delineate Lys PTM functions and show promise for a diverse set of biomedical applications.


Lysine/metabolism , Acetylation , Lysine Acetyltransferases/metabolism , Methylation , Protein Methyltransferases/metabolism , Small Molecule Libraries/chemistry , Small Molecule Libraries/metabolism , Ubiquitin-Specific Proteases/metabolism , Ubiquitination
9.
Elife ; 92020 06 05.
Article En | MEDLINE | ID: mdl-32501215

Histone acetylation regulates chromatin structure and gene expression and is removed by histone deacetylases (HDACs). HDACs are commonly found in various protein complexes to confer distinct cellular functions, but how the multi-subunit complexes influence deacetylase activities and site-selectivities in chromatin is poorly understood. Previously we reported the results of studies on the HDAC1 containing CoREST complex and acetylated nucleosome substrates which revealed a notable preference for deacetylation of histone H3 acetyl-Lys9 vs. acetyl-Lys14 (Wu et al, 2018). Here we analyze the enzymatic properties of five class I HDAC complexes: CoREST, NuRD, Sin3B, MiDAC and SMRT with site-specific acetylated nucleosome substrates. Our results demonstrate that these HDAC complexes show a wide variety of deacetylase rates in a site-selective manner. A Gly13 in the histone H3 tail is responsible for a sharp reduction in deacetylase activity of the CoREST complex for H3K14ac. These studies provide a framework for connecting enzymatic and biological functions of specific HDAC complexes.


Histone Deacetylases/metabolism , Histones/metabolism , Nucleosomes/metabolism , Acetylation , Co-Repressor Proteins/genetics , Co-Repressor Proteins/metabolism , Histone Deacetylases/genetics , Histones/genetics , Humans , Mi-2 Nucleosome Remodeling and Deacetylase Complex/genetics , Mi-2 Nucleosome Remodeling and Deacetylase Complex/metabolism , Nerve Tissue Proteins/genetics , Nerve Tissue Proteins/metabolism , Nucleosomes/genetics
10.
Methods Mol Biol ; 2133: 1-13, 2020.
Article En | MEDLINE | ID: mdl-32144660

Expressed protein ligation is a method of protein semisynthesis and typically involves the reaction of recombinant protein C-terminal thioesters with N-cysteine containing synthetic peptides in a chemoselective ligation. The recombinant protein C-terminal thioesters are produced by exploiting the action of nature's inteins which are protein modules that catalyze protein splicing. This chapter discusses the basic principles of expressed protein ligation and recent advances and applications in this protein semisynthesis field. Comparative strengths and weaknesses of the method and future challenges are highlighted.


Protein Engineering/methods , Recombinant Proteins/chemistry , Biocatalysis , Cysteine/chemistry , Esters/chemistry , Gene Expression , Inteins , Peptides/chemistry , Protein Splicing , Recombinant Proteins/biosynthesis , Sulfhydryl Compounds/chemistry
12.
Curr Org Synth ; 16(3): 369-384, 2019.
Article En | MEDLINE | ID: mdl-31984899

In the past two decades, a plethora of lysine (Lys) posttranslational modifications (PTMs) has been discovered on proteins, major groups are acylation, alkylation, and ubiquitination. Although considered biologically important, functional annotation of proteins with Lys PTMs has largely fallen behind the discovery. One grand challenge of characterizing proteins with PTMs is the procurement of homogenously modified proteins. To resolve this obstacle, sophisticated methods have been developed. These include total synthesis, semisynthesis that is based on native chemical ligation, expressed protein ligation, and enzyme-catalyzed peptide ligation, and the amber-suppression based noncanonical amino acid mutagenesis technique that may need to couple with follow-up bioorthogonal chemistry. This review summarizes currently identified significant PTMs and chemical biology methods for their installation in proteins. We hope that the current review will provide helpful insights and critical perspectives to this important research frontier.


Chemistry Techniques, Synthetic/methods , Lysine/metabolism , Protein Processing, Post-Translational , Proteins/chemical synthesis , Proteins/metabolism , Humans , Proteins/chemistry
13.
Chemistry ; 23(49): 11732-11737, 2017 Sep 04.
Article En | MEDLINE | ID: mdl-28500859

As an important epigenetic mark, lysine methylations play critical roles in the regulation of both chromatin and non-chromatin proteins. There are three levels of lysine methylation, mono-, di-, and trimethylation. Each one has turned out to be biologically distinctive. For the biochemical characterization of proteins with lysine methylation, multiple chemical biology methods have been developed. This concept article will highlight these developments and their applications in epigenetic investigation of protein functions.


Lysine/metabolism , Proteins/metabolism , Chromatin/chemistry , Chromatin/metabolism , Histones/metabolism , Humans , Methylation
14.
Angew Chem Int Ed Engl ; 56(6): 1643-1647, 2017 02 01.
Article En | MEDLINE | ID: mdl-28042700

Using amber suppression in coordination with a mutant pyrrolysyl-tRNA synthetase-tRNAPyl pair, azidonorleucine is genetically encoded in E. coli. Its genetic incorporation followed by traceless Staudinger ligation with a phosphinothioester allows the convenient synthesis of a protein with a site-specifically installed lysine acylation. By simply changing the phosphinothioester identity, any lysine acylation type could be introduced. Using this approach, we demonstrated that both lysine acetylation and lysine succinylation can be installed selectively in ubiquitin and synthesized histone H3 with succinylation at its K4 position (H3K4su). Using an H3K4su-H4 tetramer as a substrate, we further confirmed that Sirt5 is an active histone desuccinylase. Lysine succinylation is a recently identified post-translational modification. The reported technique makes it possible to explicate regulatory functions of this modification in proteins.


Escherichia coli Proteins/genetics , Escherichia coli/genetics , Lysine/analysis , Protein Processing, Post-Translational , Acylation , Amino Acyl-tRNA Synthetases/genetics , Azides , Histones/genetics , Lysine/genetics , Norleucine/analogs & derivatives , Norleucine/genetics
15.
Angew Chem Int Ed Engl ; 56(1): 212-216, 2017 01 02.
Article En | MEDLINE | ID: mdl-27910233

Using the amber suppression approach, Nϵ -(4-azidobenzoxycarbonyl)-δ,ϵ-dehydrolysine, an allysine precursor is genetically encoded in E. coli. Its genetic incorporation followed by two sequential biocompatible reactions allows convenient synthesis of proteins with site-specific lysine dimethylation. Using this approach, dimethyl-histone H3 and p53 proteins have been synthesized and used to probe functions of epigenetic enzymes including histone demethylase LSD1 and histone acetyltransferase Tip60. We confirmed that LSD1 is catalytically active toward H3K4me2 and H3K9me2 but inert toward H3K36me2, and methylation at p53 K372 directly activates Tip60 for its catalyzed acetylation at p53 K120.


2-Aminoadipic Acid/analogs & derivatives , Escherichia coli/genetics , Lysine/analogs & derivatives , Mutagenesis, Site-Directed/methods , 2-Aminoadipic Acid/genetics , Genetic Code , Histones/chemistry , Histones/genetics , Humans , Lysine/chemistry , Lysine/genetics , Methylation , Models, Molecular , Protein Processing, Post-Translational , Tumor Suppressor Protein p53/chemistry , Tumor Suppressor Protein p53/genetics
16.
J Ethnopharmacol ; 194: 987-1004, 2016 Dec 24.
Article En | MEDLINE | ID: mdl-27773803

ETHNOPHARMACOLOGICAL RELEVANCE: As a group of important medicine plants, Boschniakia rossica (Cham. et Schltdl) Fedtsch. and B. himalaica Hook.f.et Thoms, which are the only two species in the genus Boschniakia (Orobanchaceae), have long been used in traditional Chinese medicine for their multiple therapeutic uses related to enhanced renal function, erectile dysfunction, defaecate and hepatoprotective. Additionally, the two species are also used as dietary supplements in wine, cosmetics, and other healthy food. AIM OF THE REVIEW: By providing comprehensive information and data of genus Boschniakia on botany, traditional medicinal uses, phytochemistry, pharmacological research and toxicology, this review aims to summary the group of natural compounds from Boschniakia discovered so far. The other aims are to reference research findings of their biological activities and functions in medicine, physiology, and cell biology to highlight the compound candidates which can be used for further drug discovery in several pharmaceutical areas including antioxidation, anticancer, anti-inflammation, anti-senile, and immunology. MATERIALS AND METHODS: All of the available information on B. rossica and B. himalaica was collected from the electronic resources (such as PubMed, SciFinder Scholar, CNKI, TPL (www.theplantlist.org), Google Scholar, Baidu Scholar, and Web of Science). RESULTS: After a comprehensive analysis of the literatures from available online sources, the results show that both species of genus Boschniakia are valuable and popular herbal medicines with potentials to cure various ailments. The phytochemical studies revealed that the chemical compositions of this genus were mainly iridoid glycosides and phenylpropanoid glycosides. To date, 112 compounds have been isolated from the genus, while their crude extracts and purified compounds have been found to possess a wide range of biological activities including anti-senile, antitumor and anticancer, anti-inflammatory, protecting liver, boost memory, anti-oxidation, anti-lipid peroxidative, and antiviral activities. CONCLUSIONS: The existing traditional uses of the genus Boschniakia have been evaluated, and the properties of the genus are summarized based on botany, phytochemistry, pharmacological research, and toxicology. This review aims to introduce the utilization and application of the genus Boschniakia to modern drug discovery, traditional medicinal plant utilization, herbal species conservation, and the development of medicinal and health-maintaining products.


Orobanchaceae/chemistry , Phytochemicals/pharmacology , Phytochemicals/therapeutic use , Plant Extracts/pharmacology , Plant Extracts/therapeutic use , China , Ethnopharmacology/methods , Humans , Medicine, Chinese Traditional/methods , Phytotherapy/methods , Plants, Medicinal/chemistry
17.
Org Biomol Chem ; 14(22): 5012-8, 2016 Jun 14.
Article En | MEDLINE | ID: mdl-27188564

Longer amyloid-beta (Aß) peptides (43 to 49 amino acids) play essential roles in the pathology of Alzheimer's disease (AD). The difficulty in the preparation of longer Aß peptides is still an obstacle to elucidate their roles in AD. Herein we report a robust and efficient strategy for the chemical synthesis of longer Aß peptides (Aß48 and Aß49). A key feature of this method is the installation of removable Arg4-tagged backbone modification groups into the hydrophobic region of Aß. This modification can improve the handling properties of the purification, ligation and mass characterization of longer Aß peptides. The practicability of the new method has been demonstrated by the successful synthesis of Aß48 and Aß49 peptides.


Amyloid beta-Peptides/chemistry , Amyloid beta-Peptides/chemical synthesis , Amino Acid Sequence , Arginine/chemistry , Chemistry Techniques, Synthetic , Hydrophobic and Hydrophilic Interactions
18.
J Am Chem Soc ; 138(10): 3553-61, 2016 Mar 16.
Article En | MEDLINE | ID: mdl-26943264

Chemical protein synthesis can provide access to proteins with post-translational modifications or site-specific labelings. Although this technology is finding increasing applications in the studies of water-soluble globular proteins, chemical synthesis of membrane proteins remains elusive. In this report, a general and robust removable backbone modification (RBM) method is developed for the chemical synthesis of membrane proteins. This method uses an activated O-to-N acyl transfer auxiliary to install in the Fmoc solid-phase peptide synthesis process a RBM group with switchable reactivity toward trifluoroacetic acid. The method can be applied to versatile membrane proteins because the RBM group can be placed at any primary amino acid. With RBM, the membrane proteins and their segments behave almost as if they were water-soluble peptides and can be easily handled in the process of ligation, purification, and mass characterizations. After the full-length protein is assembled, the RBM group can be readily removed by trifluoroacetic acid. The efficiency and usefulness of the new method has been demonstrated by the successful synthesis of a two-transmembrane-domain protein (HCV p7 ion channel) with site-specific isotopic labeling and a four-transmembrane-domain protein (multidrug resistance transporter EmrE). This method enables practical synthesis of small- to medium-sized membrane proteins or membrane protein domains for biochemical and biophysical studies.


Membrane Proteins/chemical synthesis , Solid-Phase Synthesis Techniques/methods , Membrane Proteins/chemistry , Models, Molecular , Peptides/chemistry
...